“…Previous pre-clinical reports have demonstrated that systemic diseases such as osteoporosis (Duarte, Cesar-Neto, Sallum, Sallum, & Nociti, 2003a) and diabetes mellitus (de Molon et al, 2013), and medications that inhibit organ transplantation (CsA therapy) (Duarte et al, 2001) can lead to modifications on bone metabolism impairing the bone healing around osseointegrated implants. Indeed, we and others have examined the effects of CsA on bone healing around dental implants (Duarte et al, 2001;El Hadary, Yassin, Mekhemer, Holmes, & Grootveld, 2011;Sakakura, Marcantonio, Wenzel, & Scaf, 2007;Sakakura, Margonar, Sartori, Morais, & Marcantonio, 2006;Sakakura et al, 2003). These studies demonstrated that the short or long-term CsA administration previous to implant placement lead to decreased bone-to-implant contact, decreased bone area around the implant threads (BAFO), and poor quality of the bone resulting in lowest torque values for implant removal (Duarte et al, 2001;El Hadary et al, 2011;Sakakura et al, 2003Sakakura et al, , 2006Sakakura et al, , 2007.…”